Elevated expression of MGb2-Ag/TRAK1 is correlated with poor prognosis in patients with colorectal cancer

Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis

(2010) Hai Shi et al.   BMC CANCER

Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients

(2010) Alexander Gaber et al.   BMC CANCER

Biomarkers for Colorectal Cancer

(2010) Takuji Tanaka et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis

(2010) Cheng-Gang Wang   WORLD JOURNAL OF GASTROENTEROLOGY

Outcome of Colonic Surgery in Elderly Patients with Colon Cancer

(2010) E. Hermans et al.   Journal of Oncology

Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer

(2009) Salvatore Siena et al.   JNCI-Journal of the National Cancer Institute

Molecular Basis of Colorectal Cancer

(2009) Sanford D. Markowitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Performance value of high risk factors in colorectal cancerscreening in China

(2009) Wen Meng et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Overview of Systemic Therapy for Colorectal Cancer

(2009) Rachel Goodwin et al.   Clinics in Colon and Rectal Surgery

Identification of TRAK1 (Trafficking protein, kinesin-binding 1) as MGb2-Ag: A novel cancer biomarker

(2008) Faming Zhang et al.   CANCER LETTERS

Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer

(2008) T. Schepeler et al.   CANCER RESEARCH

Targeted therapy of cancer: new roles for pathologists in colorectal cancer

(2008) Stanley R Hamilton   MODERN PATHOLOGY

Prognostic and predictive factors in colorectal cancer

(2008) I Zlobec et al.   POSTGRADUATE MEDICAL JOURNAL

Identification and distribution of thioredoxin-like 2 as the antigen for the monoclonal antibody MC3 specific to colorectal cancer

(2008) Yuanyuan Lu et al.   PROTEOMICS